The BIRCH trial data discussed by Dr Peters
A new standard of care for advanced lung cancer: what’s next for pembrolizumab?
Exciting current topics in lung cancer
Mechanisms of resistance to checkpoint inhibitors in melanoma
Response rates to immunotherapy in sarcoma patients and implications for future therapies